[1
]
Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Berlin,
Germany. Electronic address: clinicalguidelines@esmo.org.
[2
]
Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale
Tumori IRCCS Fondazione Pascale, Napoli, Italy.
[3
]
Department of Dermatology, University Hospital Zürich, Zürich, Switzerland.
[4
]
Department of Dermatology, Gustave Roussy, Villejuif, France; Paris-Saclay University,
Le Kremlin-Bicêtre, France.
[5
]
Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation
Trust, Manchester, UK.
[6
]
Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek,
Amsterdam, The Netherlands.
[7
]
Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
[8
]
Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
[9
]
Department of Experimental and Clinical Oncology, Istituto Oncologico Veneto, IOV-IRCCS,
Padova, Italy.
[10
]
National Center for Cancer Immune Therapy, Department of Oncology, Herlev and Gentofte
Hospital, Herlev, Denmark; University of Copenhagen, Copenhagen, Denmark.
[11
]
Department of Surgery, The Angeles Clinic, Cedars Sinai Medical Center, Los Angeles,
USA.
[12
]
Department of Dermatology and Skin Cancer, Aix Marseille University, Hôpital De La
Timone, Marseille, France.
[13
]
First Department of Medicine, National and Kapodistrian University of Athens, School
of Medicine, Athens, Greece.
[14
]
Department of Radio-Oncology, University Hospital Zürich, University of Zürich, Zürich,
Switzerland.
[15
]
Department of Academic Surgery, Royal Marsden NHS Foundation Trust, London, UK.
[16
]
Department of Dermatology, Medical University of Vienna, Vienna, Austria.
[17
]
AP-HP Dermatology, Université de Paris, Paris, France; INSERM U976, Hôpital Saint
Louis, Paris, France.
[18
]
Early Phase Clinical Trials Unit, Maria Sklodowska-Curie National Research Institute
of Oncology, Warsaw, Poland.
[19
]
Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital,
Bergamo, Italy.
[20
]
Department of Medical Oncology, Hospital General Universitario Gregorio Marañon, Madrid,
Spain.
[21
]
Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK.
[22
]
Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium.
[23
]
Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences,
Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Surgery,
Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden; Wallenberg
Centre for Molecular and Translational Medicine, University of Gothenburg, Sweden.
[24
]
Dermatology Service, Hospital Clínic of Barcelona and University of Barcelona, Barcelona,
Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain;
CIBER, Instituto de Salud Carlos III, Barcelona, Spain.
[25
]
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National
Research Institute of Oncology, Warsaw, Poland.
[26
]
Department of Dermatology, University Hospital Würzburg, Würzburg, Germany.
[27
]
Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA.
[28
]
Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer
Center, Houston, USA.
[29
]
Department of Dermatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
[30
]
Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland.
